gopatzgo
Posted - 1 day ago
$ONCY wasn't this at $1.35 not that long ago ? WTF happened?
WalterHWhite
Posted - 2 days ago
$ONCY Another buying opportunity ! Christmas in November !
ringo16
Posted - 2 days ago
$ONCY this seems to be the new promising technology https://pubmed.ncbi.nlm.nih.gov/38966076/
Myman2
Posted - 2 days ago
$ONCY They should present management with an award for the most miserable small biotech stock 10 years running!! This could be dead for 6 months.
Cerberus_79
Posted - 2 days ago
$ONCY What a Garbage... Hide behind Good actions for the humanity...What a Scoundrels
saxy4u
Posted - 3 days ago
$ONCY: The IRENE trial is a phase 2 study examining the combination of pelareorep and Incyte’s anti-PD-1 antibody, retifanlimab, for metastatic triple-negative breast cancer (TNBC). The focus is on demonstrating efficacy in increasing the immune response within tumors, which historically present challenges due to their immunosuppressive nature The AMBUSH trial involves a combination therapy of pelareorep and Merck’s anti-PD-1 therapy, pembrolizumab (Keytruda), targeting solid tumors, Preliminary results suggest that pelareorep increases immune cell infiltration into tumors, which could significantly improve responses when used alongside checkpoint Mayo Clinic and Dr. Rice have shown promising preclinical. Notably, This is a critical breakthrough because CAR T cells have been largely ineffective in solid tumors due to their immunosuppressive environments  .
CaseyLe
Posted - 4 days ago
$ONCY did some rummaging and found the website creator for ONCY for what it’s worth. https://www.creativepace.com/case-study/oncolytics-biotech-pharma-content-marketing/
Article_AI
Posted - 4 days ago
$ONCY Oncolytics Biotech (ONCY) Gets a Buy from RBC Capital RBC Capital analyst Douglas Miehm assigned a Buy rating to Oncolytics Biotech (ONCY – Research Report) yesterday and set a price target of C$6.00. ... https://www.stck.pro/news/ONCY/93122418/
Cerberus_79
Posted - 4 days ago
$ONCY What a Huge Scam... Hope for a big lawsuit soon
mosh123
Posted - 5 days ago
$ONCY management should be more transparent on the call . not a clue about partnership, same old same old.
saxy4u
Posted - 5 days ago
$ONCY Dude is dropping his shares today that’s why we are down 8%! Thank GOD!
Myman2
Posted - 5 days ago
$ONCY What can you say? Another year at a $1
CarbonaraBull
Posted - 5 days ago
$ONCY Now I don't want to say absurd things but if it were to be acquired, what price could it reach? Is there a range?
CaseyLe
Posted - 5 days ago
$ONCY I was pleased to find that we had a spotlight on Stockhouse at number four, top biotech buy recommendations. I’ll be here next year if that’s what it takes.
saxy4u
Posted - 6 days ago
$ONCY was there anything about Coffey?
FoxM07
Posted - 6 days ago
$ONCY nothing new. Delays and catalysts pushed back. As we all already knew, except for Canadafan & Noteable, accelerated approval is multiple yrs away and was never impending. One can surmise from the call that there's no blackout and partnership talks are early in the game. Why doesn't BP want Pela?
Dude1234
Posted - 6 days ago
$ONCY Well looks like I'm done here guys.
Sorry to say but I'm going to be selling my position here over the next couple months. I'll monitor for any positive news, but just not seeing anything for 2024
Take care everybody.
De_man
Posted - 6 days ago
$ONCY This is from the 2nd quarter cc 1)We entered into a collaboration with GCAR for inclusion of pela in an adaptive registration enabling pancreatic cancer trial, and expect to finalize the master protocol for pela, gemcitabine, nab-paclitaxel and atezolizumab in the second half of 2024. This is from the 3rd quarter cc press release 1)H1 2025: Finalize master protocol for the adaptive registration-enabling trial for pelareorep, gemcitabine, nab-paclitaxel, and atezolizumab in first-line pancreatic ductal adenocarcinoma (PDAC) with the Global Coalition for Adaptive Research (GCAR) and submit it to the FDA At least it is only pushed back 6 months so far and now only about 2 years away (2027) before the readout so things are looking up. yes, sarcasm is involved
Myman2
Posted - 6 days ago
$ONCY This is the first time I have heard them mention discussions with current collaborators Pfizer and Roche by name and said others in the Asian region and biotechs My take is they are still 1-2 years away, but hearing something in regard to future funding would go a long way!
CaseyLe
Posted - 6 days ago
$ONCY I didn’t hear the call. 📞 - assuming it was as generic as a Walmart deli pizza. Tasteless and bland.
DoctrBenway
Posted - 6 days ago
$ONCY I like that they thank their investors at the close of each quarterly. I like their science, but they're a small company trying large things. I'm continuing to hold and expect some bumpy times before the stock pays off. Their call is worth listening to, should you wish to hear what can be done by a small, dedicated company that doesn't lavish shares and compensation on themselves.
Bho2014
Posted - 6 days ago
$ONCY reverse split coming before end of 2024
gopatzgo
Posted - 6 days ago
$ONCY go back to bed I thought we'd see partnership news
Birch1
Posted - 6 days ago
$ONCY I expect they will talk about health of CEO and Partnership to move things forward. Gut is no RS.
Notyourfatherstrades
Posted - 6 days ago
$ONCY
GB1996
Posted - 1 week ago
$ONCY Unusual to have an earnings release on Tuesday morning. Most of the time the release dates of Oncy (with no news) are on Wednesdays (aftermarket), Thursdays and Fridays. Doesn't mean anything by the way.. Just an observation
